This message was sent to ##Email##
Advertisement
|
|
|
|
| |
 The early bird deadline is Wednesday, Oct. 16. Register now so you don’t miss this $100 savings! Earn the CE and CEPTC credits you need at the Transplant Nursing Symposium.
An attendee of the 2017 Symposium said, “I really enjoyed the networking opportunities and potential for future collaborations this meeting allows. I will certainly attend in the future and encourage transplant staff to do the same.”
 Be a part of the Transplant Nursing Photo Contest! Snap a picture that conveys your experience as a transplant nurse and ITNS members will vote for their favorite image.
It's easy! Simply email your favorite transplant nursing-related photo with a title, short description, and signed permission form for everyone that appears in the photo.
Visit the ITNS website for full contest details. Email all submissions to Rita Wirth, ITNS Staff, at rwith@itns.org by Friday, Oct. 4, 2019.
ITNS's purpose is to support the professional and educational needs of transplant nurses throughout their careers. You, our members, are a vital part of the transplant nursing community that cares for a special patient population and their families.
You can make a difference for your transplant nursing colleagues! Share with your friends the benefits of membership in ITNS and encourage them to join ITNS.
 |
|
Promoted by
Veloxis Pharmaceuticals
Follow the journeys of kidney transplant patients who transitioned to a different immunosuppression regimen. After talking with their doctors about their experiences with other options, they decided to make a switch.
Watch video
|
|
The Atlantic
Doctors and scientists have long sought ways to preserve organs. Biologists now report a new strategy tested on five human livers: supercooling the organ to four degrees Celsius below zero, or just under 25 degrees Fahrenheit. This is below the freezing point of water, but the liver, perfused with a special solution, is never actually frozen. “When you touch it, it’s soft and there’s no ice,” says Shannon Tessier, a bioengineer now at Massachusetts General Hospital and co-author of the new study.
READ MORE
The Lancet
Serious chronic medical conditions occur in childhood cancer survivors. Researchers aimed to investigate incidence of and risk factors for end-organ damage resulting in registration on a waiting list for or receiving a solid organ transplantation and five-year survival following these procedures.
READ MORE
By Chelsea Adams
 More than a dozen scientific research papers have been retracted amid suspicions the organs used in the studies came from executed Chinese prisoners. During August, the journals PLOS ONE and Transplantation retracted 15 studies after questions regarding the source of donated organs were posed. The studies were originally published between 2008 and 2014 and dealt with kidney and liver transplants. Two additional journals have also expressed concern regarding published studies.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Over the long-term, graft survival may be impacted by factors such as declining adherence, which may be affected by complex dosing regimens and neurotoxicities. Studies show a direct correlation between rejection losses and nonadherence, which is also proven to increase over time. Review 2-year published data and see the results achieved at 2 years in de novo kidney transplant patients.
See the data
|
Institute for Operations Research and the Management Sciences via ScienceDaily
Eighteen people die every day waiting for transplants, and a new patient is added to the organ transplant list every 10 minutes. Much of the problem surrounds the lack of registered donors. New research in the INFORMS journal Management Science provides incentives that could lead to a solution and ultimately save lives.
The study looks at national transplant data from the Organ Procurement and Transplantation Network. Ultimately, the researchers — Tinglong Dai of Johns Hopkins University, Ronghuo Zheng of The University of Texas at Austin, and Katia Sycara of Carnegie Mellon University — concluded that the solution is a two-part method: a combination of the donor-priority rule, and instituting a freeze-period. To test their solution, the researchers created a simulated organ market.
READ MORE
Wyss Institute for Biologically Inspired Engineering at Harvard via ScienceDaily
Artificially grown human organs are seen by many as the "holy grail" for resolving the organ shortage, and advances in 3D printing have led to a boom in using that technique to build living tissue constructs in the shape of human organs. However, all 3D-printed human tissues to date lack the cellular density and organ-level functions required for them to be used in organ repair and replacement.
Now, a new technique called SWIFT (sacrificial writing into functional tissue), created by researchers from Harvard's Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Sciences, overcomes that major hurdle by 3D printing vascular channels into living matrices composed of stem-cell-derived organ building blocks, yielding viable, organ-specific tissues with high cell density and function. The research is reported in Science Advances.
READ MORE
Cardiology Advisor
The new definition of pulmonary hypertension has demonstrated validity in a study recently published in CHEST, which showed an association between elevated pulmonary vascular resistance and increased risk for mortality within 30 days of heart transplant. This risk can be sustained even with lower pulmonary arterial pressures.
READ MORE
Infectious Disease Advisor
Pneumococcal colonization rates are low in recipients of solid organ transplants, but most of the colonizing serotypes are not included in pneumococcal vaccines, according to study results published in BMC Infectious Diseases.
READ MORE
Moscow Institute of Physics and Technology via Medical Xpress
Russian researchers from the Moscow Institute of Physics and Technology, the Institute of Cell Biophysics, and elsewhere have shown an antioxidant compound known as peroxiredoxin to be effective in treating kidney injury in mice. The study in Cell and Tissue Research reports tripled survival rates in test animals treated with the chemical prior to sustaining an ischemia reperfusion injury. The team says peroxiredoxin also offers prospects for longer kidney transplant storage.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
